Humedix Co Ltd (200670.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7200670008
Humedix Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 161.87 bn KRW | 170.05 bn KRW |
| Gross profit | 75.00 bn KRW | 79.52 bn KRW |
| Operating income | 43.14 bn KRW | 42.33 bn KRW |
| EBIT | 48.41 bn KRW | 63.88 bn KRW |
| Net income | 39.26 bn KRW | 51.79 bn KRW |
| Diluted EPS – continuing operations | 3,808.37 KRW | 4,664.33 KRW |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Humedix Co Ltd
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
More stocks
- Thessaloniki Water Supply & Sewerage Co S.A (EYAPS.AT)
- Forcelead Technology Corp. (6996.TWO)
- Value Added Technology Co. Ltd (043150.KQ)
- Atha Energy Corp. (SASK.V)
- Firy Inc. (FIRY)
- EASTERN CO (EML)
- TBI Motion Technology Co Ltd (4540.TW)
- Trisul S.A (TRIS3.SA)
- Sparebank 1 Nordvest (SNOR.OL)
- Thor Medical ASA (TRMED.OL)
- Petrus Resources Ltd (PRQ.TO)
- Akwel SA (AKW.PA)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.